Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.160 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
37 38 Next >
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
WHY: NEW YORK, NY - (NewMediaWire) - February 08, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of... 
Via TheNewswire.com
Topics Lawsuit
Why Is WiMi Hologram Cloud (WIMI) Stock Up 22% Today?
WiMi Hologram Cloud stock is taking off on Thursday with speculative trading as it rallies alongside another Chinese hologram company. 
Via InvestorPlace
CASSAVA DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cassava To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
Is There Any Hope for Cassava Sciences Stock?
Battered by controversy, this company will need to show real results to prosper. 
Via The Motley Fool
(SAVA) - Analyzing Cassava Sciences's Short Interest
 
Via Benzinga
MicroCloud Hologram (HOLO) Stock Pops Another 10% in Speculative Rally
MicroCloud Hologram stock is taking off on Thursday as speculative traders continue to bet on HOLO shares following a recent rally. 
Via InvestorPlace
Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial
SAVA stock jumped 9% on Wednesday after Casava Sciences shared promising results of a clinical trial of its Alzheimer's treatment. 
Via InvestorPlace
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending
The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam continuously for 24 months. "We're fighting Alzheimer's disease by testing... 
Via Benzinga
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
From Cassava Sciences, Inc.
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of... 
Via NewMediaWire
Topics Lawsuit
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of... 
Via TheNewswire.com
Topics Lawsuit
3 small-cap biotechs with potential breakthroughs in 2024
These small-cap biotech stocks feature large addressable markets combined with positive analyst sentiment and potential breakthroughs in 2024. 
Via MarketBeat
Topics Bankruptcy
Cassava ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SAVA
From The Rosen Law Firm, P.A.
Via Business Wire
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
3 Biotech Stocks to Sell in January Before They Crash and Burn
The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell. 
Via InvestorPlace
Cassava Sciences Stock Continues Showing Rising Relative Strength
Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Portfolio Protection: 7 Risky Stocks to Drop Right Now
Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail. 
Via InvestorPlace
New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution
Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today. 
Via InvestorPlace
Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders
From Cassava Sciences, Inc.
Via GlobeNewswire
3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
Wall Street analysts foresee up to 316% upside in three fast-paced companies in the new year. 
Via The Motley Fool
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. 
Via Benzinga
Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Why Cassava Sciences Stock Zoomed 21% Higher This Week
The company has chosen an offbeat way to keep its investors sweet. 
Via The Motley Fool
Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days
Cassava Sciences sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
Although Cassava Sciences’ issuance of warrants presents risks, the underlying Phase 3 trial support boosted SAVA stock. 
Via InvestorPlace
Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday. 
Via Benzinga
Topics Stocks
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
From Cassava Sciences, Inc.
Via GlobeNewswire
What's Going On With Cassava Sciences Stock?
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday on continued upward momentum. The stock has gained more than 20% over than last five days. What To Know: 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.